Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma

Journal of Investigative Dermatology

Volumn 138, Issue 3, 2018, Pages 527-533

  Jansen, Maud H E ^a,b   Mosterd, Klara ^a,b   Arits, Aimee H M M ^a,b,c   Roozeboom, Marieke H ^a,b   Sommer, Anja ^d   Essers, Brigitte A B ^e   van Pelt, Han P A ^f   Quaedvlieg, Patricia J F ^g   Steijlen, Peter M ^a,b,c   Nelemans, Patty J ^h   Kelleners Smeets, Nicole W J ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d Parkweg Clinic Sommer   (Netherlands)

^e Department of Clinical Epidemiology and Medical Technology Assessment ^*  (Netherlands)

^f VIECURI MEDICAL CENTER   (Netherlands)

^g Zuyderland Medical Centre   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; FLUOROURACIL; IMIQUIMOD; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE EFFECTIVENESS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; SKIN BIOPSY; SUPERFICIAL BASAL CELL CARCINOMA; VERY ELDERLY; ANALOGS AND DERIVATIVES; BASAL CELL CARCINOMA; COMPARATIVE STUDY; CUTANEOUS DRUG ADMINISTRATION; MORTALITY; OINTMENT; PHOTOCHEMOTHERAPY; SKIN TUMOR;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; FEMALE; FLUOROURACIL; HUMANS; IMIQUIMOD; MALE; MIDDLE AGED; OINTMENTS; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 85042511254     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2017.09.033     Document Type: Article

References (23)

1. Arits, A.H., Mosterd, K., Essers, B.A., Spoorenberg, E., Sommer, A., De Rooij, M.J., et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 14 (2013), 647–654.
2. Arits, A.H., Spoorenberg, E., Mosterd, K., Nelemans, P., Kelleners-Smeets, N.W., Essers, B.A., Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma. Br J Dermatol 171 (2014), 1501–1507.
3. Basset-Seguin, N., Ibbotson, S.H., Emtestam, L., Tarstedt, M., Morton, C., Maroti, M., et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 18 (2008), 547–553.
4. Bath-Hextall, F., Ozolins, M., Armstrong, S.J., Colver, G.B., Perkins, W., Miller, P.S., et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 15 (2014), 96–105.
5. Com-Nougue, C., Rodary, C., Patte, C., How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma. Stat Med 12 (1993), 1353–1364.
6. Cosgarea, R., Susan, M., Crisan, M., Senila, S., Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol 27 (2013), 980–984.
7. Essers, B.A.B., Arits, A.H., Hendriks, M.R., Mosterd, K., Kelleners-Smeets, N.W., Patient preferences for the attributes of a non-invasive treatment for superficial Basal cell carcinoma: a discrete choice experiment. [e-pub ahead of print] Br J Dermatol, 2017, 10.1111/bjd.15782 (accessed 3 November 2017).
8. Flohil, S.C., Seubring, I., van Rossum, M.M., Coebergh, J.W., de Vries, E., Nijsten, T., Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol 133 (2013), 913–918.
9. Gollnick, H., Barona, C.G., Frank, R.G., Ruzicka, T., Megahed, M., Maus, J., et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 18 (2008), 677–682.
10. Gross, K., Kircik, L., Kricorian, G., 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 33 (2007), 433–439 discussion 440.
11. Housman, T.S., Feldman, S.R., Williford, P.M., Fleischer, A.B. Jr., Goldman, N.D., Acostamadiedo, J.M., et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48 (2003), 425–429.
12. Lomas, A., Leonardi-Bee, J., Bath-Hextall, F., A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166 (2012), 1069–1080.
13. Martin, I., Schaarschmidt, M.L., Glocker, A., Herr, R., Schmieder, A., Goerdt, S., et al. Patient preferences for treatment of basal cell carcinoma: importance of cure and cosmetic outcome. Acta Derm Venereol 96 (2016), 355–360.
14. Medicijnkosten. www.medicijnkosten.nl; 2017 (accessed 12 September 2017).
15. Quirk, C., Gebauer, K., De'Ambrosis, B., Slade, H.B., Meng, T.C., Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis 85 (2010), 318–324.
16. Roozeboom, M.H., Arits, A.H., Mosterd, K., Sommer, A., Essers, B.A., de Rooij, M.J., et al. Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial. J Invest Dermatol 136 (2016), 1568–1574.
17. Roozeboom, M.H., Arits, A.H., Nelemans, P.J., Kelleners-Smeets, N.W., Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 167 (2012), 733–756.
18. Roozeboom, M.H., Nelemans, P.J., Mosterd, K., Steijlen, P.M., Arits, A.H., Kelleners-Smeets, N.W., Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol 172 (2015), 739–745.
19. Szeimies, R.M., Ibbotson, S., Murrell, D.F., Rubel, D., Frambach, Y., de Berker, D., et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 22 (2008), 1302–1311.
20. Tinelli, M., Ozolins, M., Bath-Hextall, F., Williams, H.C., What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial. BMC Dermatol, 12, 2012, 19.
21. Trakatelli, M., Morton, C., Nagore, E., Ulrich, C., Del Marmol, V., Peris, K., et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol 24 (2014), 312–329.
22. Weston, A., Fitzgerald, P., Discrete choice to experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma. Pharmacoeconomics 22 (2004), 1195–1208.
23. Williams, H.C., Bath-Hextall, F., Ozolins, M., Armstrong, S.J., Colver, G.B., Perkins, W., et al. Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial. J Invest Dermatol 137 (2017), 614–619.